BridgeBio Oncology Therapeutics, Inc. BBOT
- BBO-10203 — Colorectal Cancer Phase 1
- BBO-10203 — Non-Small Cell Lung Cancer Phase 1
- BBO-10203 — Pancreatic Ductal Adenocarcinoma Phase 1
PI3Ka (1 companies · 3 programs)
Companies with an active program directed at PI3Ka.